{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Standard acute treatment for optic neuritis to hasten visual recovery May be vision-saving in cases of NMOSD or MOGAD while awaiting antibody results\n\n*   **Treatment:** Oral Prednisone taper\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** To follow IV pulse therapy Dosing regimen depends on confirmation of etiology (e.g., requires slower taper for MOGAD to prevent rebound)\n\n*   **Treatment:** Long-term Immunosuppression (e.g., Rituximab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires confirmed diagnosis of NMOSD or MOGAD via antibody testing Not indicated for isolated idiopathic optic neuritis or NAION\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"Standard acute treatment for optic neuritis to hasten visual recovery\", \"May be vision-saving in cases of NMOSD or MOGAD while awaiting antibody results\"]}, {\"treatment\": \"Oral Prednisone taper\", \"timing\": \"Delay\", \"reasons\": [\"To follow IV pulse therapy\", \"Dosing regimen depends on confirmation of etiology (e.g., requires slower taper for MOGAD to prevent rebound)\"]}, {\"treatment\": \"Long-term Immunosuppression (e.g., Rituximab)\", \"timing\": \"Delay\", \"reasons\": [\"Requires confirmed diagnosis of NMOSD or MOGAD via antibody testing\", \"Not indicated for isolated idiopathic optic neuritis or NAION\"]}]"
}